Kerrisdale Advisers’s Inogen INGN Stock Holding History

Kerrisdale Advisers’s Portfolio INGN Stock Details INGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-9,500	Closed	-$337K	–	69
2020 Q2	$337K	Hold	9,500	–	–	0.04%	61
2020 Q1	$491K	Buy	+9,500	New	+$456K	0.09%	53

Other funds holding INGN

BCM

Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return

NHAS

Novo Holdings A/S Hellerup, Denmark $1.72B AUM 106.92% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Kerrisdale Advisers's INGN Position: Q3 2020 in Review

Kerrisdale Advisers sold out of Inogen (INGN) in Q3 2020, closing a stake of 9,500 shares — an estimated $337K sold.

Kerrisdale Advisers first reported a position in INGN in Q1 2020 and held it in 2 quarters. The position peaked at $491K in Q1 2020. 151 funds tracked by Wall St. Rank hold INGN as of Q3 2020.

Kerrisdale Advisers reported no remaining Inogen position as of Q3 2020 after selling out during the quarter.
Kerrisdale Advisers sold 9,500 Inogen shares in Q3 2020, an estimated $337K.
Kerrisdale Advisers first reported a position in Inogen in Q1 2020 and held it in 2 quarters.
Kerrisdale Advisers's Inogen position peaked at $491K in Q1 2020.
151 funds tracked by Wall St. Rank held Inogen as of Q3 2020.

Based on Kerrisdale Advisers's 13F filing for Q3 2020, filed 16 Nov 2020.